RLH-033, a novel, potent and selective ligand for the σ1 recognition site

Robert L. Hudkins, Richard B. Mailman, Diane L. DeHaven-Hudkins

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

RLH-033 [2-(4-phenylpiperidinyl)ethyl 1-(4-nitrophenyl)cyclopentanecarboxylate HCl] is a rationally designed ligand that was synthesized and evaluated for its binding affinities at σ1 and σ2 sites in guinea pig brain. RLH-033 has high affinity (Ki = 50 pM) for σ1 sites labeled by [3H](+)-pentazocine, while it has over 2000-fold less affinity at σ2 sites labeled by [3H]1,3-di(2-tolyl)guanidine (DTG) in the presence of 500 nM (+)-pentazocine (Ki = 105 nM). Unlike its potent σ activity, the compound has little affinity for dopamine D1 (Ki = 2.9 μM), D2 (Ki = 2.35 μM), muscarinic M1 (Ki = 0.88 μM) or M2 (Ki = 1.7 μM) receptors, and none at all for N-methyl-D-aspartate, phencyclidine and opioid receptors. Thus, RLH-033 is the most potent σ1 ligand reported to date, and its very high affinity suggests it may be a useful radioligand to characterize the pharmacology of σ1 recognition sites.

Original languageEnglish (US)
Pages (from-to)235-236
Number of pages2
JournalEuropean Journal of Pharmacology
Volume271
Issue number1
DOIs
StatePublished - Dec 12 1994

All Science Journal Classification (ASJC) codes

  • Pharmacology

Fingerprint

Dive into the research topics of 'RLH-033, a novel, potent and selective ligand for the σ<sub>1</sub> recognition site'. Together they form a unique fingerprint.

Cite this